Humoral and Cellular Immune Responses to a Second Dose of COVID-19 Vaccine BNT162b2 in People Receiving Methotrexate or Targeted Immunosuppression: A Cohort Study

Mahil, S. K.; Bechman, K.; Raharja, A.; Domingo--Vila, C.; Baudry, D.; Brown, M.; Cope, A.; Dasandi, T.; Khan, H.; Lechmere, T.; Malim, M.; Meynell, F.; Pollock, E.; Sychowska, K.; Barker, J.; Norton, S.; Galloway, J.; Doores, K.; Tree, T.; Smith, C.

Mahil, S. K.; Bechman, K.; Raharja, A.; Domingo--Vila, C.; Baudry, D.; Brown, M.; Cope, A.; Dasandi, T.; Khan, H.; Lechmere, T.; Malim, M.; Meynell, F.; Pollock, E.; Sychowska, K.; Barker, J.; Norton, S.; Galloway, J.; Doores, K.; Tree, T.; Smith, C..

Arthritis & Rheumatology ; 73:4126-4130, 2021.

Article in English | Web of Science | ID: covidwho-1728307

Keywords

Rheumatology

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Language: English Journal: Arthritis & Rheumatology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML